Maximizing Clinical Outcome Assessments Conference
Conference - Alexandria, VA, United States
Clinical Outcome Assessments within the pharmaceutical industry provide critical data to researchers to support a variety of claims, from safety to cost-effectiveness, to regulatory bodies as well as healthcare providers and third-party payers. While outcomes information has been collected for some time, and both from a wide variety of sources and in varied formats, there has been little harmonization in the ultimate reporting and utilization of this critical information. Pharmaceutical executives are eager to maximize the use of outcome assessments, but must understand the optimal tools that will enable them to effectively collect, validate, and analyze the information gathered from patients, clinicians and proxy care-givers. The Q1 Clinical Outcome Assessments conference will provide an opportunity for executives throughout the industry for high-level education and networking, blending perspectives from academia, industry-veterans, and regulatory authorities.
Organization: Q1 Productions
(Courtesy of Q1 Productions' logo, via fdalawyersblog.com)
Maximizing Clinical Outcome Assessments Conference
Mon, Jan 13, 2014 - Tue, Jan 14, 2014
Alexandria, VA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
